Bisphosphonates in breast cancer patients with skeletal metastases.
The utility of bisphosphonates is well established in the treatment of acute hypercalcemia of malignancy. Bisphosphonates may also decrease the complications and morbidity of skeletal metastases. This article emphasizes the use of bisphosphonates in breast cancer patients with skeletal metastases.
Shapiro
C L
CL
Breast Evaluation Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans
D004164:Diphosphonates